CompaniesGenos

Genos

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

0

As Collaborator

3

Total Enrollment

5,374

By Status

COMPLETED: 2UNKNOWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
NCT02037789
NCT02037763
Hover over trial bars to see details

Recent Trials

NCT04788433Collaborator
Registry of Coronavirus Complications - CORRELATION WITH GLYCOMIC PROFILE in COVID-19 Patients
N/ACompleted
374 participants
Started: Mar 4, 2021 · Completed: Sep 10, 2022
NCT02037763Collaborator
A Prospective Trial to Identify Biomarkers Involved in the Transition From Acute to Persistent Chronic Low Back Pain
N/AUnknown
5,000 participants
Started: Dec 31, 2014 · Completed: Aug 31, 2018
NCT02037789Collaborator
"A Retrospective Study to Identify New Omics Biomarkers of Chronic/Persistent Low Back Pain"
N/ACompleted
Started: Mar 31, 2014 · Completed: Feb 29, 2016
Related Companies
Nantomics
acquired